{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:14:57Z","timestamp":1790874897718,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015131","name":"Foundation for Sarcoidosis Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015131","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.rmed.2022.106819","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T17:39:12Z","timestamp":1647625152000},"page":"106819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The association of baseline sarcoidosis measurements with 6-month outcomes that are of interest to patients: Results from the On-line Sarcoidosis Assessment Platform Study (OSAP)"],"prefix":"10.1016","volume":"196","author":[{"given":"Marc A.","family":"Judson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Recai","family":"Yucel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Preston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0723-8209","authenticated-orcid":false,"given":"Edward S.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Culver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabeel","family":"Hamzeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse E.","family":"Lower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadera J.","family":"Sweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Valeyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7973-1604","authenticated-orcid":false,"given":"Marcel","family":"Veltkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Victorson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1484-260X","authenticated-orcid":false,"given":"Jennifer L.","family":"Beaumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7038-9459","authenticated-orcid":false,"given":"Noopur","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2253-9520","authenticated-orcid":false,"given":"Tricha","family":"Shivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Vancavage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Baughman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.rmed.2022.106819_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00141-2018","article-title":"Sarcoidosis: patient treatment priorities","volume":"4","author":"Baughman","year":"2018","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.rmed.2022.106819_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.rmed.2016.02.011","article-title":"The three tiers of screening for sarcoidosis organ involvement","volume":"113","author":"Judson","year":"2016","journal-title":"Respir. Med."},{"issue":"Supplement_6","key":"10.1016\/j.rmed.2022.106819_bib3","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.1513\/AnnalsATS.201707-564OT","article-title":"Disease burden and variability in sarcoidosis","volume":"14","author":"Gerke","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"8","key":"10.1016\/j.rmed.2022.106819_bib4","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1513\/AnnalsATS.201511-760OC","article-title":"Sarcoidosis in America. Analysis based on health care use","volume":"13","author":"Baughman","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.rmed.2022.106819_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rmed.2017.09.003","article-title":"Toxicity risk from glucocorticoids in sarcoidosis patients","volume":"132","author":"Khan","year":"2017","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2022.106819_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00408-019-00206-7","article-title":"The burden of sarcoidosis symptoms from a patient perspective","volume":"197","author":"Voortman","year":"2019","journal-title":"Lung"},{"issue":"5","key":"10.1016\/j.rmed.2022.106819_bib7","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/MCP.0000000000000602","article-title":"Patient perspectives in sarcoidosis","volume":"25","author":"van Helmondt","year":"2019","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.rmed.2022.106819_bib8","doi-asserted-by":"crossref","DOI":"10.1513\/AnnalsATS.202011-1467OC","article-title":"Barriers to care among patients with sarcoidosis: a qualitative study","author":"Harper","year":"2021","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.rmed.2022.106819_bib9","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1378\/chest.125.3.997","article-title":"Health-related quality of life of persons with sarcoidosis","volume":"125","author":"Cox","year":"2004","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.rmed.2022.106819_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00408-018-0144-4","article-title":"Needs, perceptions and education in sarcoidosis: a live interactive survey of patients and partners","volume":"196","author":"Moor","year":"2018","journal-title":"Lung"},{"issue":"2","key":"10.1016\/j.rmed.2022.106819_bib11","first-page":"149","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. American thoracic society\/European respiratory society\/world association of sarcoidosis and other granulomatous disorders","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"8","key":"10.1016\/j.rmed.2022.106819_bib12","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An official American thoracic society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.rmed.2022.106819_bib13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/biomet\/63.3.581","article-title":"Inference and missing data","volume":"63","author":"Rubin","year":"1976","journal-title":"Biometrika"},{"issue":"1","key":"10.1016\/j.rmed.2022.106819_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11749-009-0138-x","article-title":"Missing data methods in longitudinal studies: a review","volume":"18","author":"Ibrahim","year":"2009","journal-title":"Test"},{"key":"10.1016\/j.rmed.2022.106819_bib15","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.rmed.2017.11.010","article-title":"Endpoints in sarcoidosis: more like IPF or asthma?","volume":"138s","author":"Judson","year":"2018","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2022.106819_bib16","first-page":"90","article-title":"Endpoints for clinical trials of sarcoidosis","volume":"29","author":"Baughman","year":"2012","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"1","key":"10.1016\/j.rmed.2022.106819_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/thoraxjnl-2012-201962","article-title":"The development and validation of the King's Sarcoidosis Questionnaire for the assessment of health status","volume":"68","author":"Patel","year":"2013","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.rmed.2022.106819_bib18","article-title":"Psychological burden associated with worse clinical outcomes in sarcoidosis","volume":"6","author":"Sharp","year":"2019","journal-title":"BMJ Open Respir Res"},{"issue":"1","key":"10.1016\/j.rmed.2022.106819_bib19","first-page":"53","article-title":"Does physical training reduce fatigue in sarcoidosis?","volume":"32","author":"Marcellis","year":"2015","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"3","key":"10.1016\/j.rmed.2022.106819_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/jpm10030097","article-title":"Benefit of wearing an activity tracker in sarcoidosis","volume":"10","author":"Drent","year":"2020","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.rmed.2022.106819_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.rmed.2016.05.010","article-title":"Predictors of fatigue in sarcoidosis: the value of exercise testing","volume":"116","author":"Strookappe","year":"2016","journal-title":"Respir. Med."},{"issue":"5261","key":"10.1016\/j.rmed.2022.106819_bib22","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","article-title":"Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation","volume":"2","author":"Scadding","year":"1961","journal-title":"Br. Med. J."},{"issue":"6","key":"10.1016\/j.rmed.2022.106819_bib23","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1183\/09031936.00060612","article-title":"Established and experimental medical therapy of pulmonary sarcoidosis","volume":"41","author":"Baughman","year":"2013","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2022.106819_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.chest.2017.07.008","article-title":"Predictors of mortality in pulmonary sarcoidosis","volume":"153","author":"Kirkil","year":"2018","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.rmed.2022.106819_bib25","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1183\/09031936.00051907","article-title":"Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial","volume":"31","author":"Judson","year":"2008","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.rmed.2022.106819_bib26","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.rmed.2008.05.001","article-title":"Differences in symptom severity and health status impairment between patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis","volume":"102","author":"Gvozdenovic","year":"2008","journal-title":"Respir. Med."},{"issue":"4","key":"10.1016\/j.rmed.2022.106819_bib27","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.rmed.2015.01.019","article-title":"The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis","volume":"109","author":"Judson","year":"2015","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.rmed.2022.106819_bib28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/MAJ.0b013e3181fe3eb2","article-title":"Impact of systemic corticosteroids on healthcare utilization in patients with sarcoidosis","volume":"341","author":"Ligon","year":"2011","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.rmed.2022.106819_bib29","doi-asserted-by":"crossref","DOI":"10.1007\/s00408-021-00455-5","article-title":"The value of a patient global assessment in management of sarcoidosis","author":"Baughman","year":"2021","journal-title":"Lung"},{"issue":"6","key":"10.1016\/j.rmed.2022.106819_bib30","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1164\/ajrccm\/145.6.1321","article-title":"A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire","volume":"145","author":"Jones","year":"1992","journal-title":"Am. Rev. Respir. Dis."},{"issue":"2","key":"10.1016\/j.rmed.2022.106819_bib31","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/rheumatology\/kel221","article-title":"Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis","volume":"46","author":"Beretta","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"2 Pt 1","key":"10.1016\/j.rmed.2022.106819_bib32","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1164\/ajrccm.156.2.9607083","article-title":"Validation of the St. George's respiratory Questionnaire in bronchiectasis","volume":"156","author":"Wilson","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmed.2022.106819_bib33","first-page":"158","article-title":"The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy-proven cases","volume":"17","author":"Pietinalho","year":"2000","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"4","key":"10.1016\/j.rmed.2022.106819_bib34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00408-019-00234-3","article-title":"Sarcoidosis and work participation: the need to develop a disease-specific core set for assessment of work ability","volume":"197","author":"Hendriks","year":"2019","journal-title":"Lung"},{"issue":"2","key":"10.1016\/j.rmed.2022.106819_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9020390","article-title":"Comprehensive care for patients with sarcoidosis","volume":"9","author":"Moor","year":"2020","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.rmed.2022.106819_bib36","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccm.2015.08.014","article-title":"Quality of life assessment in sarcoidosis","volume":"36","author":"Judson","year":"2015","journal-title":"Clin. Chest Med."},{"issue":"Pt 3","key":"10.1016\/j.rmed.2022.106819_bib37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1348\/1359107041557048","article-title":"Measuring fatigue in sarcoidosis: the fatigue assessment scale (FAS)","volume":"9","author":"De Vries","year":"2004","journal-title":"Br. J. Health Psychol."},{"issue":"1","key":"10.1016\/j.rmed.2022.106819_bib38","first-page":"19","article-title":"The WASOG Sarcoidosis Organ Assessment Instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"5","key":"10.1016\/j.rmed.2022.106819_bib39","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1183\/09031936.00000914","article-title":"Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis","volume":"44","author":"Judson","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2022.106819_bib40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","article-title":"Spirometric reference values from a sample of the general U.S. population","volume":"159","author":"Hankinson","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2022.106819_bib41","first-page":"56","article-title":"Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force","volume":"28","author":"Baughman","year":"2011","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"5 Suppl 1","key":"10.1016\/j.rmed.2022.106819_bib42","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.mlr.0000258615.42478.55","article-title":"The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years","volume":"45","author":"Cella","year":"2007","journal-title":"Med. Care"},{"issue":"7","key":"10.1016\/j.rmed.2022.106819_bib43","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1164\/rccm.201410-1785OC","article-title":"Validation and important differences for the sarcoidosis assessment tool. A new patient-reported outcome measure","volume":"191","author":"Judson","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611122000841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611122000841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T18:57:00Z","timestamp":1714589820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611122000841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":43,"alternative-id":["S0954611122000841"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2022.106819","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association of baseline sarcoidosis measurements with 6-month outcomes that are of interest to patients: Results from the On-line Sarcoidosis Assessment Platform Study (OSAP)","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2022.106819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106819"}}